Pharma industry needs to develop entire value chain: Dr Reddy's G V Prasad

According to Prasad, the relevance of Indian pharma sector as a provider of affordable alternative to the world remains intact

Indian pharmaceutical companies need to rework their chain of work because of the US-China trade war and China exiting polluting sectors like chemicals, said G V Prasad, chairman of Confederation of Indian Industry’s national committee on the industry.
 

Indian drug companies have been dependent on the drug intermediates produced by Chinese companies owing to cheaper prices, but the situation has now changed with US Government's tough stance on Chinese products, besides the shutting down of low-value and high polluting chemicals and intermediate manufacturing units by China itself.

Prasad, who is co-chairman and managing director of Dr Reddy's Laboratories Limited, said